Exenatide (Ex-4) and liraglutide are effective in modulating key pathways involved in neurodegeneration, such as apoptosis, mitochondrial function, and autophagy, in models of AD and PD
Global Market Development# Recommendation : Survodutide Reason : Developed by Boehringer Ingelheim for global markets with Phase 3 SYNCHRONIZE trials enrolling patients internationally
Circumstance: Starting GLP-1 medications Suggested interval: Baseline, then every 36 months Circumstance: Stable diabetes management Suggested interval: Every 6 months Circumstance: Poor diabetes control Suggested interval: Every 3 months Circumstance: General health screening Suggested interval: Annually Why early detection matters Regular monitoring enables early detection of medication side effects, treatment resistance, or developing complications before symptoms appear
Investing in retatrutide could be a pivotal step towards achieving better health outcomes
Wegovy 7.2mg is listed as a solution for injection in a pre-filled pen
Patients who tolerate a medication well enough to continue taking it are a self-selected group
